The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia.
Neame
P B
PB
Department of Laboratory Medicine, Hamilton Civic Hospitals, Ontario, Canada.
Soamboonsrup
P
P
Quigley
J G
JG
Pewarchuck
W
W
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000276:immunology / Q000627:therapeutic use; D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D016465:Bone Marrow Purging / Q000379:methods; D016026:Bone Marrow Transplantation; D006801:Humans; D016130:Immunophenotyping; D007167:Immunotherapy; D007938:Leukemia / Q000175:diagnosis / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D011379:Prognosis
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor